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Abatmct : A comparative study of isodidemnine- 1 and dkkmrdn B ia presental using apuWmw@cmethods, partial degra- 
dation and partial synthesis. Tbia leads to the conch&on of the presence ofa sin& depsipeptide, namely didem& B, with 
(3S,4R,SS) isxtatine instead of the previous staline residue. An attempt to determjne the whole conformation in solution of 
didemninBbyusingZD-NMRisahodesa’ibed. 
Over the last decade, the widely-distributed or er of Aplowobranchiata (Phylum Chotdata, Clam Ascidiacea), one of 
thecolonialf~ofUrochordata,hasbeenrheobjectofintensechemieal~~yby~~researchgroups [l].TheMlial 
intereat for the family of Didemnidae - probably derivated from the family of Polycitoridae in the course of evolution [ 2]- 
waspromptedbythep~~~fo~d~~t~~d~r~~ [3lfromaCfurlbeantunicate(THdidemnwnsp, 
possibly TrioYidemnum tyampborum) [4]. This led to the isolation of a new class of novel cyclic dep@e@idea c lled the di- 
Figure 1: Structure of Didemmin B 
demnina [S], andtonumerousreportsof pharnw&gicalstudkaofthesenewagentu [6].Morerecently,thesQuctwzofan- 




bodied organisms todevelop the art of chemws(fromllpidsbJpeptided)a@nsttheirpruwm.Duringthe=studias,we 
181 
Residue ‘N 13C 
CDcl3 Pyr-D5(-20T) CDC13 
!?H 4.03&Q:5;3) ~~~~~~~~~~.~~ 55.0 (d} 
7.15 (d9 5) 
SC-H 1.77 (m) 2.57 (m) 
SC-CH30.8 (overlap) 1.15 (d,7) :::: . 8 
6C-H2 l.l5(oveAap) 1.67 (m,7;?;?) 24.9 (t) 
1.35 (overlap) 1.44 (I&7;?;?) 
7C-H3 0.85 (overlap) 1.08 (t,7) 11.4 (q) 
3C-H 4.01 (overlap) 4.83 (t,lo;lO) 67.3 (d) 
ZC-H2 b 3.21 fd,l6.8) 4.40 (d,l8) 29.7 (t) 
a 2.55(dd,16.8;10)3.OQ (dd,lO;lB) 
OH 2.91 (bs1 
ae .I 
NH 7.75 (d,7.5) 8.59 (d,9) 
aC-H 4.74 (bt,9.5;?) 5.17 (ddd,9;2.5;8.5) 49.4 (d) 
@Z-Hz 1.56 (m) ~.79(d~,i~lO.~2.5)41.1 (t) 
1.15 (mf 1.51~~,1~8.~4.5~ 
$-Hz 1.45 (m) 1.76 @,10.5;7;4.5) 24.8 {t) 
yC-CH3 0.85 (67) 0.93 (d.7) (a) 
(a) 
2C-CH3 1.27 (d,7) 
4C-H 5.11 (d.3.5) 
SC-H 2.29 (m) 













N-CH3 2.50 (s) 2.51 (s) 38.6(q) 
UC-H 3.53(overlap) 4.32 (dd,10.5;4) 65.8(d) 
g-H2 3.ll(dd,4;15.7) 3.51(dd,10.5;I4) 33.8 (t) 
3.3O(dd,lo;15.7 3.59 (dd,l4;4) 
AromHo 6.79 (d,7) 7.02 (d,8.5) 129.6 (d) 
Hm7.01 (d,7) 7.27 (d,8.5) 129.8 (d) 
0CH3 3.63 (s) 3.70 (s) 54.7 w 
R&due t Ii 1% 
CDcl, Pyr-D5(-20°C) CDC13 
C-H 4.32 (q.7) 
CR3 
ti; 3’71’ 
1.23 (d,7) . , 4::; ZZ 
OH 3.34 (bs) 
prollne 
aC-H 4.77 (dd,8;4.5) 4.70 (m) 56.7 (d) 
fKMi2 1.91 (m)- 1.64 (m) 27.9 (t) 
2.16 (m) 1.78 (m) 
$X2 1.91 (m) 1.38 (m) 24.9 @) 
2.16 (m) 1.41 (m) 
i%C-H2 3.51 (m) 3.23 fm) 46.8 (t) 
3.61 (m) 3.46 (m) 
3.18 (s) 31.4 (9) 
aC-H 5.32@,12;2) 5.79(dd,11.5;3.5) 54.3(d) 
&Xi2 1.64 (m) 1.65 (m) 36.2 (t) 
1.77 (m) 1.95 fm) 
G-H 1.34 (m) 1.40 (m,7;6.5) 27.0(d) 
yC-CH3 0.80 (d,7) 0.94 (d,7) (a) 
0.80 (d,7) 0.80 (d.6.5) (a) 
me 
NH 7.59 (d,5) 8.45 (d,6) 
UC-H 4.49 (dd,5;2) 5.04 (dd,6;1.5) 56.8(d) 
@Xi 5.34(qd.2;6.5) 5.8l(qd,l.5;4.5) 69.9(d) 
@XH3 1.32 (d,6.5) 1.79 {d,6.5) i6.0&) 
proline 
aC-H 4.58 (dd,?;?) 4.65 (m) 56.1(d) 
W-H2 1.71 (In) 1.90 (m) 28.3(t) 
2.06 (m) 2.00 (m) 
F-H2 I.96 (m) 1.67 (m) 26.0 (t) 
2.06 (m) 1.67 (m) 
&Z-H2 3.55 (m) 3.67 cm) 46.8 (t) 
3.63 (m) 3.97 (m) 
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S~elu~Themold~stncturalfedwasd(lplaysdby2DNMR(1H-1Hco6y)inC~,whsn acon- 




unit)alreadyrevisedbyM.M.JouBi6 [14]. WewedMatfey’smethod [15]incoml&mUonwithHtodetem&etheab- 




configuration for MeLeu and (3S,4R,SS) for iaoSta. Taking into account the revision of the structure for didemnin Bby Rhte- 
hart[l7],itwasclearthatwehadisolatedthesameprodua. 
Onthe contrary, i&&mnin-1 lookeddiffaentwithitsposltlveoptlcal~~~(+70°) andits (3S,4R,SR) or 
(3R,4S,5S) isoSta [7].As~d~-lwaealsoaverypotentd,ourfiratideawastos~~~~~~~ 
towm~theirconformationinsoh~tion. Afterthefirs~cpectroscopic,weeuspe&dthatisodidenmin-1 anddidem- 
uinBwereinfactthesameproduct. 
In order to confidently prove it, we focused our attention loa fragment of didemnin containing the ieostatyl residue and 
undertookthe ~~~Ofthis~~~ThecydodepslpeptidedidemninBcontainingtwoallrali-labllebonds, the pecific 
clavage of these bonds hould lead to the peptide Lac - Ro - DMeLeu -Thr - isoSta. Perallel elkaline hydrolysis of isodi- 
demnin-laudofoursample,followedbymethyhUonwithdiezomethane [7],g v acomplexmixturefromwhichonlythe 
expected peptide was identitied after isolation by silica gel chromatography (CH $lfleOH 92f8) followed by reverse phase 
HPLC.Thenaturalpeptidefromboth~gavethesameHPLCretentiontimeandidmtical HNMRspectra.Inanat- 
tempt to unambigoualy assign the stereo&em&y of the isoSta residue, this peptide ~89 compared fmwith synthetic Lac - 
Pro-DMeLeu-Thr- (3R.4S.5S)isoSta-OMerelatedtothepresomptiveevidencesprevioustyproducedandthen~~the 
synthetic analogue in which (3R,4S,5S) isoSta w&8 replaced by the (3S,4R,5S) diastereoisomet in agreement with this study 
andtherecentrevisedstructurefordidemninB.[g] 
The peptide sequence was readily produced by coupling ieoStaOEt to Lac - Pro - DMeLeu -Thr in order to minimize 
the number of steps after the introduction ofiso& (the mcst inacce&ble of the five start@ residues). Furthermore, we de- 
liberetely chose to couple the readily obtained ethylester of isoSta, instead of the required methyl ester, in order to submit 
bothsyntheticandnaturalcompoundstothesameexperimentalconditionsprevioustothefinalpuriftcation(i.e. saponifica- 
tion followed by diaxomethane m thylation). The BOP went [ 16) was succe&ully employed to prepare the dipeptidea 
Lac-ProotBu and DMeLeu-ThrOMe. Subsequent coupling of both segme-ntawea b t achieved, but only in acceptable yield, 
by using BOP-Cl as previously d&bed [ 191, cmuming that segment coupling on a prolyl residue would produce minimum 
epimerisation. The (3S,4R,5S) isomer of isoSta we.9 obtained from D ello Be and the (3R,4S,5S) isomer from Ile following a 
reportedprocedure[2O].Sincethtsexoticaminoaddweslocetedatthe~~tnminusofthetargeteequence,weused 
BOPachlvati~forwuplingLac-Pro-DMeLeu-’IhrwithStainordertominimize cemisation [II)]. %ponificatkmofthe 
carboxylgxnupintheftipeptide, follawedbyCH2Nt~~~~p~ee~~u~~.Chromatographicpurifi- 
cationaffordedthep~methylesterprotectedpeptidein4oo/6ov~~yield. Onl thesyntheticcompoundbuiltupfromthe 
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Table 2 : lH BJYR deta far ,$&I ma&m rotmmer 
Lac-Pro-DMeLeu-Tlu-hoSta-OMe @“&! 
WMI (31,48.58) iaoSta With (3SW4R.5S) Wosta 
















UC-H 5.06 dd 
BC-HZ 1.67-1.65 m 
yC-H 1.40 m 




















































































order to see the negative enhancements, 89 nothing could be observed at room temperature - ROESY techniques were also 
employed(mainlyinC&) atroanntemperaturedtheobeervedpoaitiveenhancrmentswsrefound tobeamhtentwith 
the NOESY data -. The molecule looked rigid under the experimental conditions, as ‘H NMR data in several solvents had 
shown didemnin B to pnsent one set of well-resolved siguals. For hstance, the large differencea (in ail the solveuta) con- 
cemingchemicalshif$andvidnalcauplingconstan$~X3-HandthegeminaldiastereotopicisoStaprotonsZC-Ha 
andZC-Hb, wereindicativeoftherigid@ofthebackbonemauucycle. ‘Ihus. itaprindpalconformation wasmucheasierto 
detenninethenexpected.Having~~theunaquivocalassignmentdtheNMR~(inCDCl3, C&audPyridine- 
4) of our depsipeptide, the NOESY data allowed us to confirm the amino acids sequence, except for the ester bond linkagea 
(Scheme 1). 
Didemnin B 185 
Scheme 1: NOB results (from NOESY and ROFSY experkents). 
LaC Pro 2 DMeLeu Thr iaosta Hip Leu Pro1 MCTyr(MC) 
dNN N..--__._-m. N N____ ___________ _________________________N 
Medinm a --------------~~~~-~~~~~~~~~_N 
and Q ____________________________p 
long 3---m-m g p ________g 
2 __________-____N 
=ge ‘I ______ _ ______ ___ ____________ _______________________Ho 
=------ Strong NOEa ------- Medium NOl9 -_______ We& NO& 
Scheme 2 : Threonine and ( 35.4R. 5s ) imStatiue conformatlom 
Table 3: NWaCH variations accordhg to solvents and to temperatore 
Reaidne CDC13 F’yr-Dg A8 CDCl3+ A8 345’K 253”k A8 DMSO 
















7.15 7.56 0.41 7128 
7.75 a.47 0.72 7.81 
7.59 8.25 0.66 7.64 
3.08 3.24 0.16 3.19 
2.50 2.64 0.14 2.55 
3.53 4.20 0.67 ? 
4.77 4.75 0.02 4.87 
4.74 5.19 0.45 4.80 
4.17 4.72 0.55 4.03 
5.11 5.65 0.54 4.99 
4.03 4.70 0.67 3.90 
4.49 5.07 0.58 4.54 
5.32 5.80 0.48 5.39 
4.58 4.72 0.14 4.70 






























7.67 0.11 6.92 
8.63 0.16 7.85 
8.49 0.24 7.77 
3.18 0.06 3.05 
2.51 0.13 2.50 
4.32 0.12 4.06 
4.70 0.05 4.63 
5.17 0.02 4.73 
4.76 0.04 3.96 
5.67 0.02 4.94 
4.73 0.03 3.82 
5.04 0.03 4.35 
5.79 0.01 5.05 
4.65 0.07 4.35 
4.48 0.05 4.04 
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During these studies, we noted some spatial tie&x accross the ring - NH Leu- aCH ‘IIu, NH Leu-2CHb iso%, aCH 
Thr-~HLeu,2cHbisosta-acHThr-,indicatlnganinternalNHLeuandthepoesibilityofanunexpectedarrangementfor 
the isoSta residue. In order to mnfnm those points, some parameters (tempera-, solvents) of COSY expe-rimena were 
changed (table 3) . Interestingly, the ef%cts involving the NH graups of Leu and isoSta re almust temperature independent 
(<0.002ppmPKintherangefrom253to345’K),inagreementwithanexpectedinternalorientation [231that muldberelat- 
ed to strong hydrogen-bridges io ide the cycle. The low solvatation for both NH isoSta nd NH L.eu was also pointed out, in 
accord with two possible hydrogen-bonds from NH isoSta to CO Leu and CO MeTyr(Me). This rationalized the NOE en- 
hancements @ZH Leu-aCH Thr and NH Lou-2CHb isosta. With the support of an internal NH L&u and of isoSta (already or- 
ganised, scheme 2), we retumed to the Hip in order to reach mnformatiooal conclusions a  NOE results were lacking for this 
residue. To rationalise this lack of long distance spin interactions, one of its cartiyl groups (3C) had to be oriented perpen- 
dicular to the medium plane of the cycle to look after the whole conformation for the rest of the cycle (accordingly tothe 
whole NOE results). That conformation for the molecule allowed us to explain the turning up of the peptidic propagation i




orientationto he medium plane (f@ure 2). 
In conclusion, we should like to point out the following points: (a) it is obvious that all didemnin B-like dcpsipeptides 
described until now from Carribean tunicates, are in factthesame one, namely dideumin B -with (3S,4R,5S) isoSta instead 
of Sta - (b) the NMR conformational analysis howed NH Leo and NH isoSta to be oriented inward (c) the f3 tommnforma- 
tionforthesidechainthatcouldplayapartint activity from 
didemnin Bto didemnin A (which is without such an organ&d side chain). However, didem& A is also a very potent drug 
indicating that he conformational picture of the cycle is, by far, the most valuable knowledge (d) the overall organisation f 
isoStawitbafree hydroxyl~upthatm~dberelatedwiththeactivityofsuchcompounds accordingtotheproteaseinbibito- 
ry effect of pepstalin (which is dependent on the free OH gnmp of Sta [ 241, with the same absolute mnfiguratioo f r the car- 
bollbearingthisOHfunctionalityinpepstati10. [25] 
The results of our study led to the conclusion that didemnio Bin solution looked like an isolated rather that a solvated 
molecule. from a mnformational point of view. The reaolting overall molecular shape (or at least, the main one that domiuated 
theequillbrium)wasfoundtoassumeaconfonnationalconstancyfrmnCDQjtoDMSO. Tbemostsuqnisiogfactmncemed 
the tail Lac-Pro 2-DMeLeu-Tbrwhere a similar conformation was found in DMSO and in apolar solvents * l . A likely expla- 
nationofsuchane&ctmuldbe&&dto thepresenceofaprollne~~andamUectionofatericallydemandingside- 
chainsallaroundthist(~~~,Leu,isoSta).WearecurrentlyundertakenNMRaddieionalexpinproticeol- 
van@ for a better understanding of tbis stable ccmformati~ that muld be related to the li~bilic nature of didemnin B
*Thisrandomamrngementwaabaeedonthegreati,Leu,RolandonthevicinalNH/ a 
CHscalarmupliog(3J=9.5Hz)forJ_eu. 
**SeetheoveraUintegrltyof&emicalshiflxintable3.More,actual1DNOEe xperimentsin DMSOindicate theprweoceof 
effeclxbetwecnNCH3Leu/NHThr, CH3LacI8CH~Pro2and aCHPro2INCH&eu,inagreemen twithalloverausimilar 
mnfolmalion for this fragment in any solvents 
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Figure 2 : Computer-~crated drawing of Mdcmxdn B in solution. 
Most of hydrogena are omitted for clarity. 








ofsemplediasohzdiuto2mlofa1:1mlxtureofglyccrolandthioglyccrol. ForGUMS-, acombinedEI/CI 
eourcewaaused.Theelectmnensrgywas70eV(El)and50eV(CI).ScanBpeedwesleec/decade.A0.32mm(i.d.)x30 
m~~column,coatsdwithOVlwas~Heliumwasthe canier gas. BGP reagent (BeuzotriazoQloxy - his (dime- 
thylamino)_ ’ hualluoro-pharrphatc)waeobtainedfrom~-chimie.AminoacidsderivativeswereoftheL 
formand~purchesedfmmBachanorNovabiochem.HPU:analysiawereperfolrmeduaingUftrasphereODSBeclaan 
1Ox25Omm(c&mnA)orUltra@emODSE$e&nau4.6x15O(columnB). 
Abbreviations and symbols follow the Mans oflUPAGIUB Joint &mmisslononBiochemicalNomen&ture 
(Eur. J. &&em. 1984, 9,138).Inadditionthefollowingabbreviationsareused: ~:(lH-1,2,3-benmtiLezo1-1-1-~~)- 
Ms(dimeUlylamino)-phosphoniumhexefluorophphate; w : N,N’-bis-(2-oxo-3-oxazolidinyl)-phosphon; 
Msy:twodimenaioaalC0lTelated Bpectroscopy ; pIEB: dlisuPropylethyl@aine; &Q& : 4-amino-3-hydroxy-S-methyl hep- 
tanoic acid; Lac : L - la& acid; NOESY : twu dimensional nu&arOverhauser enhamement L3peamqy; &A : 4-amino-3- 
hydroxy-6-methylheptauoicaci& TFA : ta%hommtic acid, 
:The lgCH2CIZexeactwasloadedontoaLH-20columnwhichwaspackedinMeOHandelu- 
tion WBI~ allowed to proceed. Four fractions were collected and the content of each fraction was evaluated by TLC (reverse 
phase C 18, MeGH/H20 9/l or7/3), u&g cl&nine vapor as visualization reagent. The main fraction (634 mg) was loaded on 
a Lowbarsilicagelcolumnwhichwaselutedin stepgradientfashionwlthaMeGH/CH 2Cl2fra&on. The main cyclodepsi- 
peptidewascontainedinthe97/3CH2QzrmeOHfraction.F~data~~~onanltesting,itwasturthapurifiedbyre- 
verse phase HPLC, monitoring by diffenmdal ~.Essentiallypurecompoundwasobtsinedasawhite~~hous 
solid (50 mg) on a Cl 8 reverse phase cdumn (50 x 1 cm) with I&OH/Water 7/3 as solvent for this puriflcatlon. 
phvsicaldata: W(MeGH):209(20000),223(14800),277(7050),284(6090):[ a]D- -70” (cO.O~,CHC~~) 
~(CHU~3680,3600,2970,2940,2880,1725,16~,1605,1~0,1510 . 
HR FAR/MS gave MH+ at 1112.6511 (calculated 1112.6416 for C57H8&Q). The fragmentionsatmlz 1040.943 and 
816~tothesequ~~cleavageofthesidechain,~z861,771,743,686,555,307and210tothecleavageof 
the~.IntheMIKEspectnrmof~zlll2,thelargelossofCOindicatedacycllcp~~.Iheaminoaddanalysls 
was performed by GC!&iS ofthe N-heptafluorobutyryl-O-propyl eater derivativea after hydrolysis by 6N HCl for 14 h at 110 
OC in a sealed tube. The unusual aminoaclds were cham&&ed as follows : N-MeLeu (EI : m/z 296,100%. M - 87; m/z 254, 
30%, loss of propene from a& 296; m/z 228, lO%, C&CONH(CH$H+; CI (CHS: m/z 384,40%, MI-I+; m/z 324, lOO%, 
loss of propaook m/z 296,80%, loss of CO from m/z 324). MewMe) (RI : m/z 360,7%, M-87; m/z 220,60%, M - C 3F7 
CON(CHdH; m/z 121, 10046, CHM4CH2+; CI (CHS: m/z 448,40%, MH+; m/z 388, lOO%, lam of propanok m/z 
360, 80%, kxa of CO fiwn m/z 388, m/z 221, SO%, MH - C&CQN(CH# isoSta @I : 552,346, M - C&g+; m/z 510, 
10%. loss of propene from m/z 552; m/z 464,15%, loss of Fppyuormiate from m/z 552; m/z 282,100%, C-C cleavage be- 
tweenaminoandhydro@lcfimctlons;CI(CH4):m/z61O,4O%,MH+;m/z396, lOO%,lossofC3F7COOH;m/z336, 
SO%, loss of propanol from m/z 396, m/z 308,40%, 1~ of CO from m/z 336; m/z 282.20%. seme origin as in the El spec- 
trum; m/z 214,70%, C&CONH3+) . 




MeTyr(Me):2.2O(NCHH3),3.40(aCH),3.23-3.36( wH2),6.72-6.82(Aromatics), 3.36 (GCH3); 
Thr:8.02(NH),4.89( aCH),5.92( fKIi),1.90( w-CHJ); 
DMeL..eu:2.97(NCH3),5.57( aCH),1.98-1.70( cHz),l.OS-1.07( yC-CH3); 
Lactic-aci&4.27(CI-I), I .38(CH3); 
Ro1:4.25(aCH)1.35(~HZ),1.27(yCHZ),3.01-3.22( 8CH& 
Pro~4,43(aCH),1.35(@ZHz),l.27(Qit),2.55(8CHz). 
: 5 mg of didemnin (our sample or iscdidemnin- 1) were solubillzed in cooled (SOC) methanol 
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synthads: Acetyl - lactyl - proline tert-butyl ester (1): BOP (17.68 g, 40 mmol) and DIEA (diimpmpylethyl amine, 6.9 ml, 
40 mmol) were stirnxlwith a solution of acetyl-lacticacid (5.28 g. 40mmol) and ofproline terGbuty1 eater (3.42 g, 20 mmol) 
inmahylenechloride(5O~).Aiter2hatroom~~empaature,thereabionmixhlr 
washedwlplKHSO4 5% (2x3Oml), thenwithNa2~5% (2x3Oml)andsaturatedNaCl(3Oml).Themixanewasdried 
over Na$304,5ltered and conaneatedundcrrcducedpressun.QlrmnadDgraphicp((opencolumndsilicagcl 
withethylacetawhexane5O/5Oesaolventmixture)yielded 5.30g(93%)of(1)asacolo&s3ail.[a]~--1200(c1,MeOH); 
lHNMR@MSOdg) 5.13 (q, J = 6.8 Hz,lH), 4.17 (dd, J = 5.2and 8.6H2, 1X-Q 3.66-3.57 (m,lH), 3.53-3.43(m,lH), 
2.21-2.08 (m,lH), 2.02 (6, 3H), 1.97-1.87 (m,lH), 1.37 (s,9H), 1.32 (d, J = 6.8 Hz,3H). Anal. Cal& forC14H2flO5: 
C, 58.93: H, 8.12; N. 4.91. Found: C, 58.80; H, 8.10; N, 5.05. 
Ace@- lactyl praline(2) : (11.98 g, 42 mmol) was stirred in t~Uuomacetic acid (20 ml) at room temperature for 2 h. 
Afterremoving~esolventunderreduced~,(2)was~byMturatingindiethylether~.O2g,73%).mp146- 
148Dc; [a]D- -114’(c 1,MeOH); lH NMR(DMSOd6) 5.14 (q, J = 6.9 Hz, Hi), 4.25 (dd, J = 5.2 and 9.5 Hz, lH), 3.66- 
3.56 (m, Hi), 3.56-3.45 (m, Hi), 2.24-2.06 (m, Hi), 2.02 (8, 3H), 1.98-1.88 (m, lH), 1.88-1.78 (m, Hi), 1.31 (d, J = 
6.9 Hz, 3H). Anal. Calcd. forCloH1flOg: C, 52.40; H, 6.60; N, 6.11. Found: C, 52.60; H, 6.75; N, 6.00. 
[N,N-(-Mel-~1~11 - thmonine methyl ester (3): BOP (6.63 g, 15 mmol) and DE?A (5.7 ml, 
15 mmol) were added to a CH& solution (20 ml) of thnxmine methyl ester (2.54 g, 15 mmol) and of Z-(NMe)-D-leu&e 
(4.19g, 15mmol)-prepared&omZ-D-~aceordingtoMcDennottand~oiton [26] -.Tbewmk-upalmadyde- 
scribed for (1) afforded crude (3) as a cokrless oil (5.73 g, 97%).[ a]D - +40” (c 1, MeOH); ‘H NMR @MS0 d6) 7.74 (m, 
lH), 7.40-7.26 (m, 5H), 5.13 (a, 2H), 4.95 (m, Hi), 4.89-4.68 (m, lH), 4.30 (dd, J = 2.0 and 9.5 Hz, Xi), 3.62 (s, 3H), 
2.80 (s, 3H), 1.64-1.56 (m, ZH), 1.48-1.34 (m, U-I), 1.05 (d, J = 7.7 Hz, 3H), 0.94-0.78 (m, 6H). Anal. Calcd. for 
Ci,jH3oN&: C, 60.90; H, 7.67; N, 7.10. Found: C, 60.75; H, 7.82; N, 7.25. 




lypreparedandfinelygnwnd[27] BOP-Cl(2.20g, 8.6mmol)wasaddedwitht1iethylamine(l.21ml,8.6mmol)toasolu- 
tionof(2)- 1.98g,8.6mmolinCH2~2(10ml)-.ThemixturewasatimdatrwmtemperatureuntilBOP-CIwaasolubi- 
lized (2 h). D-MeLeu-Tbr-OMe, HCl(2.56 g, 8.6 mmol) was then addedwithtriethylamine (1.21 ml, 8.6 mmol) and the 
rcaultingmixtures&redovendgbt. Theaf ornnmtioncdwork-up[sa(1)]fumishedcrude(4)whichwaspurifiedbycristalli- 
sationindiethylether(2.92g, 72%); mp 169-170°C, [a]D- +12O (c 1, MeOH); ‘H NMR (DMSOd6) 7.38 (d, J = 8.3 Hz, 
IH), 5.21 (q, J = 6.8 Hz, lH), 5.16 (dd, J = 4.4 and 9.8 Hz, lH), 4.87 (d. J - 9.3 Hz, HI), 4.80 (d, J = 7.8 Hz, Hi), 
4.29 (dd, J = 3.4 and 8.3 Hz, lH), 4.18-4.07 (m. lH), 3.81-3.73 (m, lH), 3.63 (8, 3H), 3.55-3.42 (m, Hi), 3.00 (6, 3H), 
2.29-2.17 (m. lH), 2.12-1.85 (m, 2H), 2.01 (6, Hi), 1.75-1.47 (m. 3H), 1.43-1.33 (m, H-l), 1.30 (d, J - 6.8 Hz, 3H), 
1.07 (d, J = 6.7 Hz, 3H), 0.89 (d, J = 6.2 Hz, 3H), 0.81 (d, J = 6.2 Hz, 3H). Anal. Cakd. for C 22H37N%: C, 56.04; H, 
7.91; N, 8.91. Found: C, 55.79: H, 7.82; N, 8.96. 
Lactyl - prolyl - [(N-methyl)-Dleucyl] - thremine (5)z 1N NaOH (15 ml) was added $opwiw to a cold solution of (4) - 
2.36g, 5mmol-inMeOH(lOml)andslinwdfor20minThcn1NHCl(15mt)wasaddedandthesolventevaporatedunder 
reduced pnxaure. The clear solution was satural witbNaCl and extract& fourtimea wlth CH ;Clz (20 ml). lXe combined or- 
ganiclayen,weredriedoverNa~sO4,filteredandconemhrated.(5)wasaystallizedby~~~indiethylether(2.oOg, 
96%);mp158-1590C;(a]~+560(c1,MeOH).Anal.CakdforC1$&N~:C, 54.93;H, 8.01; N,lO.ll.Foun& C, 
55.09; H. 7.92; N, 9.96. 
Lactyl - pxopyl - [(N-methyl)-D-leucyl] - threonyl - (3R,4S,5S)- is&atin methyl ater (6a): coupling between (5) - 0.91 
g, 2.2 mm01 - and the triflwmawta@ saltoithe(3R4S,SS)-ieostatinethylener-0.63g,2~ol-wasaccomp~~inthe 
same conditionsalreadydesaibedfor(3)andafWdedthe. canrspondlngpeprldeesafoam(l.lOg).Thiscrudenslduewas 
ssponifiedtofurnishthcacid(0.9g)whichwas~p~y~u~inMeOHand~~FlatedwitfiCH2N2unhUp~- 
lowmlour. After&e aolventwasremoved, thenaiduewsspurlPiedbylowprrssufechromatDgraphyonaLowbarcahunn 
(Merck; size B; elutionwtthMeOH/CH$& 5/95) to affoni (6a) aa a foam (0.5 g. 43%).[ a]r +41* (c 1, MeOH); lIi NW? 
(see table 2). Anal. Cakd. for C2&#4C$: C, 57.32; H, 8.59; N, 9.55. Found: C, 57.05; H, 8.65; N, 9.70. HPLC ml- 
umn B (MeoH, l%TPAiWatex, l%TPA 50/50) tr6.14mn. TLC Rf 0.33, CH &$/l&OH95/5. 
Lactyl - prolyl - [@methyl)-D-leucyl] - threxmyl - (3S,4R,5S) - &c&atih methyl eater (6b): By a similar procedure, 
(6b) was obtained as a foam (0.47 g, 40%).[ a]D- +36” (c 1, MeOH); lH NMR (see table 2). Found for C2gH#4C$ C, 
57.06; H, 8.69; N, 9.48. HPLC mlumn B (MeOH, l%‘IFA/Water, l%TFA 50/50) tr-8.49nm. TLC Rf 0.27, CH $ld 
MeOH 95f5. 
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